Pekin Hardy Strauss’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Pekin Hardy Strauss's CRL Position: Q3 2026 in Review
Pekin Hardy Strauss reduced its Charles River Laboratories (CRL) stake by 70% in Q3 2026, selling an estimated $1.1M and leaving 1,826 shares worth $539K. The position accounts for 0.05% of the portfolio, ranked #297.
Pekin Hardy Strauss first reported a position in CRL in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.83M in Q2 2025. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Pekin Hardy Strauss held 1,826 shares of Charles River Laboratories worth $539K as of Q3 2026.
- Pekin Hardy Strauss sold 4,186 Charles River Laboratories shares in Q3 2026, an estimated $1.1M.
- Charles River Laboratories made up 0.05% of Pekin Hardy Strauss's portfolio in Q3 2026, its #297 holding.
- Pekin Hardy Strauss first reported a position in Charles River Laboratories in Q1 2025 and has held it in 7 quarters since.
- Pekin Hardy Strauss's Charles River Laboratories position peaked at $5.83M in Q2 2025.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Pekin Hardy Strauss's 13F filing for Q3 2026, filed 2 Nov 2026.